Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent

Teruhiko Shigeoka, Masaharu Murata, Shohei Yamaguti, Takeshi Mori, Takuro Niidome, Yoshiki Katayama, Makoto Hashizume

Research output: Contribution to conferencePaperpeer-review


Advances in molecular imaging provide new insights into the pathophysiology of many diseases. In this research, we have development functional molecule for MRI contrast agent of the liver. The agent, LAC-DOTA, is expected accumulation into hepatocytes. The molecular imaging ability of LAC-DOTA was measured by measuring the liver imaging ability of a normal mouse and a liver cirrhosis mouse. The LAC-DOTA enhanced MRI imaging may be emerged as a promising modality for detection and diagnosis of liver cirrhosis.

Original languageEnglish
Number of pages1
Publication statusPublished - 2006
Event55th SPSJ Annual Meeting - Nagoya, Japan
Duration: May 24 2006May 26 2006


Other55th SPSJ Annual Meeting

All Science Journal Classification (ASJC) codes

  • Engineering(all)


Dive into the research topics of 'Magnetic resonance imaging for liver cirrhosis using functionalized contrast agent'. Together they form a unique fingerprint.

Cite this